acth (4-10) has been researched along with enkephalin, ser(2), leu(5), thr(6)- in 1 studies
Studies (acth (4-10)) | Trials (acth (4-10)) | Recent Studies (post-2010) (acth (4-10)) | Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) |
---|---|---|---|---|---|
187 | 15 | 3 | 224 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Konoplya, AI; Sever'yanova, LA; Shveinov, IA; Smakhtin, MY | 1 |
1 other study(ies) available for acth (4-10) and enkephalin, ser(2), leu(5), thr(6)-
Article | Year |
---|---|
DSLET and ACTH(4-10) increase mitotic activity of hepatocytes and suppress antibody production.
Topics: Adrenocorticotropic Hormone; Analgesics; Animals; Antibodies; Dose-Response Relationship, Drug; Enkephalin, Leucine; Hepatocytes; Mice; Mice, Inbred CBA; Mitosis; Nootropic Agents; Peptide Fragments | 2003 |